Skip to main content

Table 2 Kaplan Maier estimate for overall response rate (ORR) and disease control rate (DCR)

From: Changing monoclonal antibody keeping unaltered the chemotherapy regimen in metastatic colorectal cancer patients: is efficacy maintained?

 

Overall survival

 

6 months

12 months

24 months

Median (CI 95%)

p value

ORR

    

0.02

     No

78.6

49.7

11.8

12(9–15)

 

     Yes

100

91.7

55.0

27(11–43)

 

DCR

     

     No

52.3

5.3

-

7(5–9)

<0.0001

     Yes

100

88.2

33.8

20(15–24)